MigraineMind research summary

Electroacupuncture Alleviates Migraine Possibly by Regulating KAT and Inhibiting nNOS Expression via the PGC-1α/PPARα/δ Signaling Pathway.

Neurochem Res | 2026

Laboratory / animal study
AuthorsZhang H, He C, Shao M, Zhang F, Li J
JournalNeurochem Res
Publication year2026
PubMed ID42986380

Summary

Electroacupuncture (EA) is being studied as a treatment for migraines. Migraines are common and can greatly affect people's lives. Researchers created a model of migraines in rats using nitroglycerin injections. They tested pain sensitivity and examined brain tissues for specific markers. The study found that EA reduced migraine symptoms in the rats. It also affected the expression of certain proteins linked to pain and inflammation. These proteins include KAT, CGRP, and c-Fos. The research suggests that EA works by influencing specific signaling pathways in the body. This might help reduce migraine pain by regulating inflammation and pain perception. Overall, the results show promise for using EA as a practical treatment for migraine sufferers. Further studies could help clarify how it works and improve migraine management strategies for patients. Clinical relevance: This study indicates that electroacupuncture may offer a new treatment option for migraine patients.

Original research

Read the original publication and review its full methods and findings on PubMed.

MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.